These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12356631)

  • 1. 7-hexanoyltaxol-eluting stent for prevention of neointimal growth: an intravascular ultrasound analysis from the Study to COmpare REstenosis rate between QueST and QuaDS-QP2 (SCORE).
    Kataoka T; Grube E; Honda Y; Morino Y; Hur SH; Bonneau HN; Colombo A; Di Mario C; Guagliumi G; Hauptmann KE; Pitney MR; Lansky AJ; Stertzer SH; Yock PG; Fitzgerald PJ
    Circulation; 2002 Oct; 106(14):1788-93. PubMed ID: 12356631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel drug-delivery stent: intravascular ultrasound observations from the first human experience with the QP2-eluting polymer stent system.
    Honda Y; Grube E; de La Fuente LM; Yock PG; Stertzer SH; Fitzgerald PJ
    Circulation; 2001 Jul; 104(4):380-3. PubMed ID: 11468196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials.
    Hoffmann R; Guagliumi G; Musumeci G; Reimers B; Petronio AS; Disco C; Amoroso G; Moses JW; Fitzgerald PJ; Schofer J; Leon MB; Breithardt G
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):499-506. PubMed ID: 16273564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detailed intravascular ultrasound analysis of Zotarolimus-eluting phosphorylcholine-coated cobalt-chromium alloy stent in de novo coronary lesions (results from the ENDEAVOR II trial).
    Sakurai R; Hongo Y; Yamasaki M; Honda Y; Bonneau HN; Yock PG; Cutlip D; Popma JJ; Zimetbaum P; Fajadet J; Kuntz RE; Wijns W; Fitzgerald PJ;
    Am J Cardiol; 2007 Sep; 100(5):818-23. PubMed ID: 17719326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of plaque calcium on neointimal hyperplasia following bare metal and drug-eluting stent implantation.
    Shimada Y; Kataoka T; Courtney BK; Morino Y; Bonneau HN; Yock PG; Grube E; Honda Y; Fitzgerald PJ
    Catheter Cardiovasc Interv; 2006 Jun; 67(6):866-9. PubMed ID: 16649232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravascular ultrasound analysis of small vessel lesions treated with the Sparrow coronary stent system: results of the CARE II trial.
    Kume T; Waseda K; Koo BK; Yock PG; Botelho R; Verheye S; Whitbourn R; Meredith I; Worthley S; Hai KT; Honda Y; Abizaid A; Fitzgerald PJ
    Catheter Cardiovasc Interv; 2014 Jan; 83(1):19-24. PubMed ID: 23413202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.
    Fischer D; Scheller B; Schäfer A; Klein G; Böhm M; Clever Y; Cremers B
    EuroIntervention; 2012 Aug; 8(4):450-5. PubMed ID: 22917728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans.
    Virmani R; Liistro F; Stankovic G; Di Mario C; Montorfano M; Farb A; Kolodgie FD; Colombo A
    Circulation; 2002 Nov; 106(21):2649-51. PubMed ID: 12438288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-stent restenosis is inhibited in a bare metal stent implanted distal to a sirolimus-eluting stent to treat a long de novo coronary lesion with small distal vessel diameter.
    Obata JE; Nakamura T; Kitta Y; Saito Y; Sano K; Fujioka D; Kawabata K; Kugiyama K
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):E777-87. PubMed ID: 23378231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up.
    Degertekin M; Serruys PW; Foley DP; Tanabe K; Regar E; Vos J; Smits PC; van der Giessen WJ; van den Brand M; de Feyter P; Popma JJ
    Circulation; 2002 Sep; 106(13):1610-3. PubMed ID: 12270850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular responses at proximal and distal edges of paclitaxel-eluting stents: serial intravascular ultrasound analysis from the TAXUS II trial.
    Serruys PW; Degertekin M; Tanabe K; Russell ME; Guagliumi G; Webb J; Hamburger J; Rutsch W; Kaiser C; Whitbourn R; Camenzind E; Meredith I; Reeves F; Nienaber C; Benit E; Disco C; Koglin J; Colombo A;
    Circulation; 2004 Feb; 109(5):627-33. PubMed ID: 14769685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis: immediate and long-term clinical and angiographic outcome.
    Liistro F; Stankovic G; Di Mario C; Takagi T; Chieffo A; Moshiri S; Montorfano M; Carlino M; Briguori C; Pagnotta P; Albiero R; Corvaja N; Colombo A
    Circulation; 2002 Apr; 105(16):1883-6. PubMed ID: 11997271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial.
    Serruys PW; Ormiston JA; Sianos G; Sousa JE; Grube E; den Heijer P; de Feyter P; Buszman P; Schömig A; Marco J; Polonski L; Thuesen L; Zeiher AM; Bett JH; Suttorp MJ; Glogar HD; Pitney M; Wilkins GT; Whitbourn R; Veldhof S; Miquel K; Johnson R; Coleman L; Virmani R;
    J Am Coll Cardiol; 2004 Oct; 44(7):1363-7. PubMed ID: 15464314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in tissue characterization of restenotic neointima between sirolimus-eluting stent and bare-metal stent: integrated backscatter intravascular ultrasound analysis for in-stent restenosis.
    Ando H; Amano T; Takashima H; Harada K; Kitagawa K; Suzuki A; Kunimura A; Shimbo Y; Harada K; Yoshida T; Kato B; Uetani T; Kato M; Matsubara T; Kumagai S; Yoshikawa D; Isobe S; Ishii H; Murohara T
    Eur Heart J Cardiovasc Imaging; 2013 Oct; 14(10):996-1001. PubMed ID: 23341147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravascular ultrasound assessment of minimum lumen area and intimal hyperplasia in in-stent restenosis after drug-eluting or bare-metal stent implantation. The Nordic Intravascular Ultrasound Study (NIVUS).
    Jensen LO; Vikman S; Antonsen L; Kosonen P; Niemelä M; Christiansen EH; Kervinen K; Erglis A; Harnek J; Kumsars I; Thuesen L; Niemelä K
    Cardiovasc Revasc Med; 2017 Dec; 18(8):577-582. PubMed ID: 29066343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT).
    Hong MK; Mintz GS; Lee CW; Song JM; Han KH; Kang DH; Song JK; Kim JJ; Weissman NJ; Fearnot NE; Park SW; Park SJ;
    Circulation; 2003 Feb; 107(4):517-20. PubMed ID: 12566359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose 7-hexanoyltaxol-eluting stent with polymer sleeves for coronary revascularization: one-year results from the SCORE randomized trial.
    Grube E; Lansky A; Hauptmann KE; Di Mario C; Di Sciascio G; Colombo A; Silber S; Stumpf J; Reifart N; Fajadet J; Marzocchi A; Schofer J; Dumas P; Hoffmann R; Guagliumi G; Pitney M; Russell ME;
    J Am Coll Cardiol; 2004 Oct; 44(7):1368-72. PubMed ID: 15464315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirolimus-eluting stent implantation and beta-irradiation for the treatment of in-stent restenotic lesions: comparison of underlying mechanisms of acute gain and late loss as assessed by volumetric intravascular ultrasound.
    Schiele TM; König A; Rieber J; Erhard I; Leibig M; Theisen K; Siebert U; Klauss V
    Am Heart J; 2005 Aug; 150(2):351-7. PubMed ID: 16086942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer.
    Grube E; Sonoda S; Ikeno F; Honda Y; Kar S; Chan C; Gerckens U; Lansky AJ; Fitzgerald PJ
    Circulation; 2004 May; 109(18):2168-71. PubMed ID: 15123533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.